About Tripartite motif-containing protein 72
Tripartite motif-containing protein 72 (TRIM72) is a protein
from Homo sapiens identified by UniProt accession
Q6ZMU5, 477 residues long.
MolForge cross-references it against 0 known binders and
167 disease associations.
Target properties
| Protein name | Tripartite motif-containing protein 72 |
| UniProt accession | Q6ZMU5 |
| Gene | TRIM72 |
| Organism | Homo sapiens |
| Length | 477 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (167)
Diseases linked to this target (Open Targets).
- breast adenocarcinoma · score 0.18
- neoplasm · score 0.10
- diabetes mellitus · score 0.09
- axial length measurement · score 0.08
- hepatocellular carcinoma · score 0.08
- coronary artery disease · score 0.07
- breast cancer · score 0.07
- exercise intolerance, riboflavin-responsive · score 0.07
- acute myocardial infarction · score 0.07
- Distal myopathy, Nonaka type · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q6ZMU5-F1 | alphafold | PREDICTED | 90.68 | — |
Amino-acid sequence (477 residues)
MSAAPGLLHQ ELSCPLCLQL FDAPVTAECG HSFCRACLGR VAGEPAADGT VLCPCCQAPT RPQALSTNLQ LARLVEGLAQ VPQGHCEEHL DPLSIYCEQD RALVCGVCAS LGSHRGHRLL PAAEAHARLK TQLPQQKLQL QEACMRKEKS VAVLEHQLVE VEETVRQFRG AVGEQLGKMR VFLAALEGSL DREAERVRGE AGVALRRELG SLNSYLEQLR QMEKVLEEVA DKPQTEFLMK YCLVTSRLQK ILAESPPPAR LDIQLPIISD DFKFQVWRKM FRALMPALEE LTFDPSSAHP SLVVSSSGRR VECSEQKAPP AGEDPRQFDK AVAVVAHQQL SEGEHYWEVD VGDKPRWALG VIAAEAPRRG RLHAVPSQGL WLLGLREGKI LEAHVEAKEP RALRSPERRP TRIGLYLSFG DGVLSFYDAS DADALVPLFA FHERLPRPVY PFFDVCWHDK GKNAQPLLLV GPEGAEA
Explore Tripartite motif-containing protein 72 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets